Literature DB >> 9802616

Genomic organization of the canine p53 gene and its mutational status in canine mammary neoplasia.

L L Chu1, G R Rutteman, J M Kong, M Ghahremani, M Schmeing, W Misdorp, E van Garderen, J Pelletier.   

Abstract

To determine whether canine malignancies share common genetic lesions with their human counterparts, and are thus potentially interesting model systems in which to pose questions regarding tumor etiology and progression, we have elucidated the entire exon/intron structure of the canine p53 gene. A search for p53 gene abnormalities in mammary tumor tissue was undertaken utilizing single strand conformation polymorphism analysis. Mutations were detected in exons 4, 5, 6, and 7 of the p53 gene and consisted of nonsense, splicing, and frameshift mutations. None of 11 benign tumors and 6 of 40 primary carcinomas (15%) were found to harbor subtle p53 mutations. In 14 carcinomas examined the results in primary tumors and metastases were the same. These findings implicate involvement of this gene in the genesis of some malignant canine tumors, in a fashion similar to their human counterparts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9802616     DOI: 10.1023/a:1006010526813

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  14 in total

Review 1.  Genetic diversity, inbreeding and cancer.

Authors:  Beata Ujvari; Marcel Klaassen; Nynke Raven; Tracey Russell; Marion Vittecoq; Rodrigo Hamede; Frédéric Thomas; Thomas Madsen
Journal:  Proc Biol Sci       Date:  2018-03-28       Impact factor: 5.349

2.  Enrofloxacin enhances the effects of chemotherapy in canine osteosarcoma cells with mutant and wild-type p53.

Authors:  D York; S S Withers; K D Watson; K W Seo; R B Rebhun
Journal:  Vet Comp Oncol       Date:  2016-06-23       Impact factor: 2.613

3.  Evaluation of adverse effects in tamoxifen exposed healthy female dogs.

Authors:  Wanessa L F Tavares; Gleidice E Lavalle; Mariana S Figueiredo; Aline G Souza; Angelica C Bertagnolli; Fernando A B Viana; Paulo R O Paes; Rubens A Carneiro; Guilherme A O Cavalcanti; Marilia M Melo; Geovanni D Cassali
Journal:  Acta Vet Scand       Date:  2010-12-22       Impact factor: 1.695

Review 4.  Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients.

Authors:  Sandeep S Patil; Ivaylo Gentschev; Ingo Nolte; Gregory Ogilvie; Aladar A Szalay
Journal:  J Transl Med       Date:  2012-01-04       Impact factor: 5.531

5.  Identification of tumour-associated and germ line p53 mutations in canine mammary cancer.

Authors:  N Veldhoen; J Watterson; M Brash; J Milner
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

6.  Evaluation of the drug sensitivity and expression of 16 drug resistance-related genes in canine histiocytic sarcoma cell lines.

Authors:  Hajime Asada; Hirotaka Tomiyasu; Yuko Goto-Koshino; Yasuhito Fujino; Koichi Ohno; Hajime Tsujimoto
Journal:  J Vet Med Sci       Date:  2015-02-21       Impact factor: 1.267

7.  Breed-predispositions to cancer in pedigree dogs.

Authors:  Jane M Dobson
Journal:  ISRN Vet Sci       Date:  2013-01-17

8.  Mutation of p53 Gene and Its Correlation with the Clinical Outcome in Dogs with Lymphoma.

Authors:  A Koshino; Y Goto-Koshino; A Setoguchi; K Ohno; H Tsujimoto
Journal:  J Vet Intern Med       Date:  2015-12-17       Impact factor: 3.333

9.  Multiplex Gene Expression Profiling of 16 Target Genes in Neoplastic and Non-Neoplastic Canine Mammary Tissues Using Branched-DNA Assay.

Authors:  Florenza Lüder Ripoli; Susanne Conradine Hammer; Annika Mohr; Saskia Willenbrock; Marion Hewicker-Trautwein; Bertram Brenig; Hugo Murua Escobar; Ingo Nolte
Journal:  Int J Mol Sci       Date:  2016-09-21       Impact factor: 5.923

10.  A 2-base insertion in exon 5 is a common mutation of the TP53 gene in dogs with histiocytic sarcoma.

Authors:  Hajime Asada; Masaya Tsuboi; James K Chambers; Kazuyuki Uchida; Hirotaka Tomiyasu; Yuko Goto-Koshino; Koichi Ohno; Hajime Tsujimoto
Journal:  J Vet Med Sci       Date:  2017-09-01       Impact factor: 1.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.